3DKnee™ System
DeviceTotal knee replacement joint for subjects with knee osteoarthritis and willing to participate in the study.
NCT Number: NCT00819481
The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Longo Orthopedics, Scottsdale, Arizona, United States
Total knee replacement surgery is widely accepted as effective treatment for degenerative joint disease (DJD), osteoarthritis and rheumatoid arthritis. Relief of patient pain and return of mobility are the primary goals that can be accomplished by this surgery. The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery. The study will take place at multiple sites across the United States and be managed by the Encore Medical Clinical Affairs Department. The study will include only patients who meet the indications for use criteria for the 3DKnee™ System and who are candidates for primary knee arthroplasty.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Total knee replacement joint for subjects with knee osteoarthritis and willing to participate in the study.
Time frame: 2 year
Time frame: 5 year
Time frame: 5 year
Time frame: 5 year
Time frame: 5 year
Time frame: 5 year
Encore Medical, L.P.
Industry
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01305356
Ankylosis, Arthritis
Tucson, Arizona, United States
View Trial DetailsNCT06235710
Arthritis, Arthritis, Rheumatoid
Brunssum, Limburg, Netherlands
View Trial DetailsNCT02686528
Arthritis, Degenerative Joint Disease
Chicago, Illinois, United States
View Trial DetailsNCT01540851
Arthritis, Degenerative Joint Disease
Boston, Massachusetts, United States
View Trial Details